Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Our Products
MouseAtlas
iPSC Cell Lines
Knockout Cell Lines
Tumor Cell Lines
Adeno-associated Virus (AAV) Standard Capsid
Featured Catalog
Humanized Mouse Models
HUGO-GT™
HUGO-Ab™
Humanized Target Gene Models
Humanized Immune System Mouse Models
Tool Mice
Cre Mouse Lines
Disease Models
Autoimmune Disease Models
Ophthalmic Disease Models
Immunodeficient Mouse Models
Metabolic Disease Models
Neurological Disease Models
Oncology & Immuno-oncology Models
Services
Model Generation Techniques
Turboknockoutᵀᴹ Gene Targeting
Cre-ESCs Gene Editing
Targeted Gene Editing
Genetically Engineered Animals
Knockin Mice
Knockin Rats
Knockout Mice
Knockout Rats
Transgenic Mice
Transgenic Rats
Transgenic Model Generation
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Adenovirus Packaging
Lentivirus Packaging
Custom Cell Line Services
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Overexpression Cell Lines
Point Mutation Cell Lines
Breeding & Supporting Services
BAC Modification
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
Drug Discovery and Development
Antibody Discovery Platform
HUGO-Ab™
HUGO-Mab™
HUGO-Light™
HUGO-Nano™
HUGO-Ab-eKO™
Therapeutic Area
Neurology
Alzheimer's Disease (AD)
Parkinson's Disease (PD)
Huntington's Disease (HD)
Blood Brain Barrier (BBB)
Metabolic & Cardiovascular
Obesity
Ophthalmology
Glaucoma
Age-Related Macular Degeneration (AMD)
Oncology
PBMC Humanized Mouse Model
Human Immune System (HIS) Mouse Model
Immunology & Inflammation
Asthma
Innovative Drug R&D
Therapeutic Antibody Drugs
Monoclonal Antibodies (mAb)
Bispecific Antibodies (BsAb)
ADC/AOC
AI-Powered AAV Discovery
Cell Immunotherapy
Gene Therapy
Oligonucleotide Therapy
Fully Human Antibody Library
Neurology Antibodies
Metabolic & Cardiovascular Antibodies
Ophthalmology Antibodies
Oncology Antibodies
Immunology & Inflammation Antibodies
Resources
News
Blogs & Insight
Promotion
Events & Webinars
Databases
AbSeek
Rare Disease Data Center
Cell iGeneEditor™ System
Citations
Resource Vault
OriCell
About Us
Animal Health & Welfare
Corporate Overview
Facility Overview
Our Team
Our Partners
Careers
Health Reports
Contact Us
Login
HomeMouseAtlas
C57BL/6NCya-Kcnv2em1/Cya
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
+
-
Organization
Job Role
Country
Catalog Type
Product Name
Main Area of Research
How did you hear about us?
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.

C57BL/6NCya-Kcnv2em1/Cya

Common Name
Kcnv2-KO
Product ID
S-KO-07205
Backgroud
C57BL/6NCya
Strain ID
KOCMP-240595-Kcnv2-B6N-VA
Status
Research and Development
When using this mouse strain in a publication, please cite “Kcnv2-KO Mouse (Catalog S-KO-07205) were purchased from Cyagen.”
KO Models
Product Type
Age
Genotype
Sex
Quantity
The standard delivery applies for a guaranteed minimum of three heterozygous carriers. Breeding services for homozygous carriers and/or specified sex are available.
+
KO Models
Basic Information
Strain Name
Kcnv2-KO
Strain ID
KOCMP-240595-Kcnv2-B6N-VA
Gene Name
Kcnv2
Product ID
S-KO-07205
Gene Alias
KV11.1
Background
C57BL/6NCya
Gene Full Name
potassium channel, subfamily V, member 2
Modification
Conventional knockout
NCBI ID
240595 (Mouse)
Phenotype
MGI:2670981
Chromosome
Chr 19 (Mouse)
Application
--
Datasheet
Click here to download >>
More
Rare Disease Data Center >>
Strain Description
Ensembl Transcript ID
ENSMUST00000056708
NCBI Transcript ID
NM_183179
Target Region
Exon 1~2
Size of Effective Region
~14.6 kb
Overview of Gene Research
Kcnv2 encodes Kv8.2, a voltage-gated potassium channel subunit. It acts as a modulator by shifting the activation range of the K+ channels in photoreceptor inner segments, playing a crucial role in the normal function of the retina [1].

Mutations in Kcnv2 are associated with an autosomal recessive cone-rod dystrophy known as KCNV2-associated retinopathy or “cone dystrophy with supernormal rod responses”. Patients with this condition typically show decreased visual acuity, reduced color vision, photophobia, nyctalopia, and nystagmus. The disease progresses slowly, and legal blindness may be reached before the age of 25. Full-field electroretinograms (ERGs) show pathognomonic waveform features, such as a disproportionate increase in b-wave amplitude with a relatively small light intensity increase, delayed a-wave and b-wave peak times, and a higher than normal b:a wave ratio. Retinal imaging reveals features like bull's eye maculopathy pattern in fundus autofluorescence (FAF) and variable foveal disruption on optical coherence tomography (OCT) [1,2,3,4].

In conclusion, Kcnv2 is essential for the normal function of retinal photoreceptor inner segments. The study of KCNV2-associated retinopathy, often through clinical and genetic analysis of patients rather than traditional KO/CKO mouse models in the provided references, has provided insights into the disease mechanism. Understanding Kcnv2's role in this disease may help develop future therapeutic strategies for this currently untreatable condition [1].

References:
1. Guimaraes, Thales A C De, Georgiou, Michalis, Robson, Anthony G, Michaelides, Michel. 2020. KCNV2 retinopathy: clinical features, molecular genetics and directions for future therapy. In Ophthalmic genetics, 41, 208-215. doi:10.1080/13816810.2020.1766087. https://pubmed.ncbi.nlm.nih.gov/32441199/
2. Georgiou, Michalis, Robson, Anthony G, Fujinami, Kaoru, Héon, Elise, Michaelides, Michel. 2020. KCNV2-Associated Retinopathy: Genetics, Electrophysiology, and Clinical Course-KCNV2 Study Group Report 1. In American journal of ophthalmology, 225, 95-107. doi:10.1016/j.ajo.2020.11.022. https://pubmed.ncbi.nlm.nih.gov/33309813/
3. Sakti, Dhimas H, Cornish, Elisa E, Ali, Haipha, Jamieson, Robyn V, Grigg, John R. 2024. Natural history and biomarkers of KCNV2-associated retinopathy. In Clinical & experimental ophthalmology, 52, 528-544. doi:10.1111/ceo.14373. https://pubmed.ncbi.nlm.nih.gov/38443311/
4. Georgiou, Michalis, Fujinami, Kaoru, Vincent, Ajoy, Zrenner, Eberhart, Michaelides, Michel. 2021. KCNV2-Associated Retinopathy: Detailed Retinal Phenotype and Structural Endpoints-KCNV2 Study Group Report 2. In American journal of ophthalmology, 230, 1-11. doi:10.1016/j.ajo.2021.03.004. https://pubmed.ncbi.nlm.nih.gov/33737031/
Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Publications
Scientific Reports
2025-05-15
Effects of different anesthetic drugs on electroretinography in mice
Read More
Contact Us
Connect with our experts for your custom animal model needs. Please fill out the form below to start a conversation or request a quote.
Inquiry Details
Main Area of Research
Service(s) of Interest
Gene of Interest
Project Details
How did you hear about us?
Contact Information
Full Name
Email
Phone Number
+
-
Organization
Job Role
Country
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our  Privacy Policy  for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0336
Email:
inquiry@cyagen.com
Services
HUGO-GT™HUGO-Ab™iPSC Cell LinesAdeno-associated Virus (AAV) Standard Capsid
Drug R&D
NeurologyMetabolicOphthalmologyOncology
About Us
Animal Health & WelfareCorporate OverviewOur TeamHealth Reports
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Global Antibody Drug Industry Development BlueBook (Frost & Sullivan)
Key Insights
The industry is undergoing a rapid transformation driven by next-generation modalities, globalized markets, and upstream technological innovations.
  • Market Structural Shift: Monoclonal antibodies drive steady growth, but ADCs and bispecifics are rapidly accelerating, reshaping the market with higher-value innovations.
  • Chinese Market Globalization: China is actively expanding globally, evidenced by a surge in high-value cross-border license-out deals.
  • Technology-Driven Efficiency: Advanced discovery engines—exemplified by Cyagen's HUGO-Ab platform and AI algorithms—are streamlining candidate screening, optimizing molecular design, and localizing the upstream supply chain.
  • Oncology-Focused Innovation: R&D pipelines remain heavily concentrated on high-incidence malignancies like non-small cell lung cancer, utilizing complex modalities to combat clinical resistance.
Now Available for Download
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest
Main Area of Research